Unitedhealth Gp SEC Filings

UnitedHealth Group Incorporated reported the results of its 2026 Annual Meeting of Shareholders. A total of 768,066,717 shares of common stock were represented. Shareholders elected nine directors for one-year terms, with support levels generally above 89% of votes cast for each nominee.

Shareholders approved, on a non-binding basis, the Company’s executive compensation, with 559,434,838 votes for and 82.74% of votes cast in favor. They also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 95.00% of votes cast in favor. A shareholder proposal to require any board chair to be independent received 20.24% support and was not approved.

UnitedHealth Group executive Christopher R. Zaetta reported a small, routine tax-related share disposition. On this Form 4, he used 134.02 shares of UnitedHealth Group common stock, valued at $377.00 per share, to satisfy tax obligations. After this tax-withholding disposition, he continues to hold 16,582.149 shares directly, indicating the transaction affects only a minor portion of his overall position and does not represent an open-market sale.

UNITEDHEALTH GROUP executive Patrick Hugh Conway, Chief Executive Officer of Optum, used company shares to cover tax obligations on equity compensation. A total of 203.821 shares of common stock were disposed of at $377.92 per share, leaving him with 17,601.17 shares held directly.

UnitedHealth Group Incorporated plans to participate in the Bank of America Securities Health Care Conference 2026. Senior leaders will answer questions in an interview-style session covering the company’s strategy, market positions, recent results and expectations for its end markets.

The session is scheduled for May 12, 2026, beginning at 11:00 a.m. Eastern Time, and a live audio webcast will be accessible through the Investor Relations page on the company’s website. The disclosure is furnished under Regulation FD and is not deemed filed or incorporated by reference into other securities law filings unless specifically referenced.

UnitedHealth Group reported Q1 2026 results with modest growth and stable profitability. Total revenues were $111,721 million, up 2% year over year, while net earnings were $6,481 million and diluted EPS was $6.90, roughly in line with 2025.

UnitedHealthcare revenues rose 2% to $86,265 million, but medical membership fell by 1.1 million people, mainly in Medicare Advantage, Medicaid and commercial risk-based products. Optum revenues were flat at $63,749 million and earnings from operations declined 15% as value-based care businesses faced elevated medical cost trends and Medicare funding pressure.

The medical care ratio improved to 83.9% from 84.8% on favorable reserve development and affordability initiatives, while the operating cost ratio increased to 13.8% due to investments and restructuring. Cash flows from operations were strong at $8,912 million. The company executed portfolio divestitures, is exiting South American operations, plans about $3.0 billion of pending acquisitions, entered forward share repurchase contracts up to $2.0 billion, and received IRS Notices of Proposed Adjustment for 2017–2020 transfer pricing, which it intends to contest.

UnitedHealth Group Inc reports that Vanguard Capital Management beneficially owned 68,122,483 shares of Common Stock as of 03/31/2026, representing 7.50% of the class. The filing states Vanguard has sole dispositive power over 68,122,483 shares and sole voting power over 9,251,706 shares. The disclosure notes ownership is held on behalf of various Vanguard affiliates and managed accounts.

UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an open-market sale of 800 shares of UnitedHealth Group common stock. The shares were sold at a price of $355.00 per share. After this transaction, he directly holds 17,804.991 shares of common stock.

Fidelity Brokerage Services LLC submitted a Form 144 notice to sell up to 800 shares of Common Stock of UNH. The filing lists two tranches that vested: 301 shares on 02/20/2026 and 499 shares on 02/21/2026. The cover shows an aggregate amount of $284,000.00 and CUSIP 907675839 with the securities traded on NYSE.

UnitedHealth Group outlines its 2026 annual meeting agenda and broad governance, leadership and pay changes. Shareholders will vote on electing nine directors, an advisory Say‑on‑Pay, ratifying Deloitte & Touche as auditor, and a shareholder proposal on requiring an independent Board chair.

The company reports 2025 revenue of $447.6 billion, net earnings of $12.1 billion, fully diluted EPS of $13.23, ROE of 12.8% and an annual cash dividend of $8.84 per share. It plans to invest nearly $1.5 billion in AI initiatives in 2026 and at least that much again in 2027.

Governance updates include combining the CEO and Chair roles under Stephen Hemsley with a strengthened Lead Independent Director, creating a new Public Responsibility Committee, refreshing committee leadership and adding former FDA Commissioner Scott Gottlieb to the Board. Pay decisions include a $60 million cliff‑vesting stock option grant to the CEO, no annual bonus, and increasing CEO stock ownership requirements, while the CFO receives a $1 million salary, targeted 2x‑salary bonus, and $8 million in stock incentives plus a $1.2 million cash award.